These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 7799357)

  • 41. Association of diffuse idiopathic skeletal hyperostosis and aortic valve sclerosis.
    Orden AO; David JM; Díaz RP; Nardi NN; Ejarque AC; Yöchler AB
    Medicina (B Aires); 2014; 74(3):205-9. PubMed ID: 24918668
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Morbidity and mortality of hospitalized patients with diffuse idiopathic skeletal hyperostosis.
    Mader R; Dubenski N; Lavi I
    Rheumatol Int; 2005 Dec; 26(2):132-6. PubMed ID: 16341904
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The prevalence of diffuse idiopathic skeletal hyperostosis in an outpatient population in The Netherlands.
    Westerveld LA; van Ufford HM; Verlaan JJ; Oner FC
    J Rheumatol; 2008 Aug; 35(8):1635-8. PubMed ID: 18528963
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Absence of an association of rheumatoid arthritis and diffuse idiopathic skeletal hyperostosis: a case-control study.
    Mata S; Wolfe F; Joseph L; Esdaile JM
    J Rheumatol; 1995 Nov; 22(11):2062-4. PubMed ID: 8596145
    [TBL] [Abstract][Full Text] [Related]  

  • 45. New developments in our understanding of DISH (diffuse idiopathic skeletal hyperostosis).
    Sarzi-Puttini P; Atzeni F
    Curr Opin Rheumatol; 2004 May; 16(3):287-92. PubMed ID: 15103260
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Metabolic factors in diffuse idiopathic skeletal hyperostosis - a review of clinical data.
    Pillai S; Littlejohn G
    Open Rheumatol J; 2014; 8():116-28. PubMed ID: 25598855
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Diffuse idiopathic dysmetabolic hyperostosis and metabolic diseases].
    Delli Gatti I; La Corte R; Bertelli R; Gilli G; Menozzi L
    G Clin Med; 1987 Oct; 68(10):501-6. PubMed ID: 3501382
    [No Abstract]   [Full Text] [Related]  

  • 48. Insulin and new bone formation in diffuse idiopathic skeletal hyperostosis.
    Littlejohn GO
    Clin Rheumatol; 1985 Sep; 4(3):294-300. PubMed ID: 3905220
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nonarticular tenderness and functional status in patients with diffuse idiopathic skeletal hyperostosis.
    Mader R; Novofastovski I; Rosner E; Adawi M; Herer P; Buskila D
    J Rheumatol; 2010 Sep; 37(9):1911-6. PubMed ID: 20551104
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of sex hormones, insulin, growth factors and peptides on cartilage health and disease.
    Claassen H; Schicht M; Paulsen F
    Prog Histochem Cytochem; 2011 Feb; 45(4):239-93. PubMed ID: 21251699
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Metabolic disturbances and synovial joint responses in osteoarthritis.
    Denko CW; Malemud CJ
    Front Biosci; 1999 Oct; 4():D686-93. PubMed ID: 10525474
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Serum levels of insulin-like growth factor in subjects with osteoarthritis of the knee. Data from the Baltimore Longitudinal Study of Aging.
    Hochberg MC; Lethbridge-Cejku M; Scott WW; Reichle R; Plato CC; Tobin JD
    Arthritis Rheum; 1994 Aug; 37(8):1177-80. PubMed ID: 8053956
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The prevalence of palpable finger joint nodules in diffuse idiopathic skeletal hyperostosis (DISH). A controlled study.
    Schlapbach P; Beyeler C; Gerber NJ; van der Linden S; Bürgi U; Fuchs WA; Ehrengruber H
    Br J Rheumatol; 1992 Aug; 31(8):531-4. PubMed ID: 1643450
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Current therapeutic options in the management of diffuse idiopathic skeletal hyperostosis.
    Mader R
    Expert Opin Pharmacother; 2005 Jul; 6(8):1313-8. PubMed ID: 16013982
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Radiographic features of the hand in diffuse idiopathic skeletal hyperostosis (DISH): comparison with normal subjects and acromegalic patients.
    Littlejohn GO; Urowitz MB; Smythe HA; Keystone EC
    Radiology; 1981 Sep; 140(3):623-9. PubMed ID: 7280223
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Prevalence and risk factors in diffuse idiopathic skeletal hyperostosis in a population sample in Hungary].
    Kiss C; Szilágyi M; Mituszova M; Poór G
    Orv Hetil; 1997 Jun; 138(25):1619-23. PubMed ID: 9265142
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Serum Dkk-1 levels of DISH patients are not different from healthy controls.
    Aeberli D; Schett G; Eser P; Seitz M; Villiger PM
    Joint Bone Spine; 2011 Jul; 78(4):422-3. PubMed ID: 21459653
    [No Abstract]   [Full Text] [Related]  

  • 58. Ultrasonography of peripheral entheses in the diagnosis and understanding of diffuse idiopathic skeletal hyperostosis (DISH).
    Mader R; Novofastovski I; Iervolino S; Pavlov A; Chervinsky L; Schwartz N; Pappone N
    Rheumatol Int; 2015 Mar; 35(3):493-7. PubMed ID: 25503650
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Increased risk of stroke in patients with diffuse idiopathic skeletal hyperostosis: a nationwide population-based cohort study.
    Cheng YY; Lin CH; Tsai PY; Chen YH; Lin SY; Chang ST
    Sci Rep; 2021 Nov; 11(1):21349. PubMed ID: 34725397
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Association between diffuse idiopathic skeletal hyperostosis (DISH) and multiple myeloma.
    Kilcoyne RF
    Skeletal Radiol; 1996 Apr; 25(3):250. PubMed ID: 8741061
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.